NCT00125775View on ClinicalTrials.gov

Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients?

PHASE4CompletedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Peritoneal DialysisRenal Disease, End-Stage

Interventions

BIOLOGICAL

Engerix-B

Engerix-B at 0, 1, 6 months

Trial Locations (1)

SAR

Prince of Wales Hospital, New Territories

All Listed Sponsors

lead

Chinese University of Hong Kong

OTHER

NCT00125775 - Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients? | Biotech Hunter | Biotech Hunter